Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Pemoline, formerly sold under the brand name Cylert among others, is a stimulant medication which was used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It has since been discontinued in most countries due to rare but serious liver toxicity. The medication was taken by mouth.
History, Community, Culture & Applications
Explore the main themes, entities and connections around Pemoline. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
liver toxicity united states stimulant effects treatment used adhd narcolepsy due drug medication however available cases japan serious stimulants potential
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Pemoline | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Pemoline | AHFS/Drugs.com | Micromedex Detailed Consumer Information | 1.00 | infobox |
| Pemoline | ATC code | N06BA05 (WHO) | 1.00 | infobox |
| Pemoline | CAS Number | 2152-34-3 N | 1.00 | infobox |
| Pemoline | ChEBI | CHEBI:7953 Y | 1.00 | infobox |
| Pemoline | ChEMBL | ChEMBL1177 Y | 1.00 | infobox |
| Pemoline | ChemSpider | 4561 Y | 1.00 | infobox |
| Pemoline | Chirality | Racemic mixture | 1.00 | infobox |
| Pemoline | CompTox Dashboard (EPA) | DTXSID3023427 | 1.00 | infobox |
| Pemoline | Drug class | Stimulant; Dopamine reuptake inhibitor; Dopamine releasing agent | 1.00 | infobox |
| Pemoline | DrugBank | DB01230 Y | 1.00 | infobox |
| Pemoline | ECHA InfoCard | 100.016.763 | 1.00 | infobox |
| Pemoline | Elimination half-life | 7–12 hours | 1.00 | infobox |
| Pemoline | Excretion | Mainly urine | 1.00 | infobox |
| Pemoline | Formula | C9H8N2O2 | 1.00 | infobox |
| Pemoline | KEGG | D00744 Y | 1.00 | infobox |
| Pemoline | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Pemoline | Legal status | BR: Class B1 (Psychoactive drugs) | 1.00 | infobox |
| Pemoline | Legal status | CA: Schedule IV | 1.00 | infobox |
| Pemoline | Legal status | DE: Prescription only (Anlage III for higher doses) | 1.00 | infobox |
| Pemoline | Legal status | US: Schedule IV | 1.00 | infobox |
| Pemoline | Metabolism | Liver | 1.00 | infobox |
| Pemoline | Metabolites | Various | 1.00 | infobox |
| Pemoline | Molar mass | 176.175 g·mol−1 | 1.00 | infobox |
| Pemoline | Other names | Pheniminooxazolidinone; Phenylisohydantoin; Phenylpseudohydantoin; Phenilone; 2-Imino-5-phenyl-4-oxazolidinone; 2-Amino-5-phenyl-1,3-oxazol-4(5H)-one | 1.00 | infobox |
| Pemoline | Protein binding | ≤50% | 1.00 | infobox |
| Pemoline | PubChem CID | 4723 | 1.00 | infobox |
| Pemoline | Routes of administration | By mouth | 1.00 | infobox |
| Pemoline | Trade names | Cylert, others | 1.00 | infobox |
| Pemoline | UNII | 7GAQ2332NK | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.